Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Change in Account Payables: 2011-2024

Historic Change in Account Payables for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to -$1.1 million.

  • Niagen Bioscience's Change in Account Payables rose 21.96% to -$938,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year increase of 382.27%. This contributed to the annual value of -$1.1 million for FY2024, which is 292.95% down from last year.
  • Per Niagen Bioscience's latest filing, its Change in Account Payables stood at -$1.1 million for FY2024, which was down 292.95% from $553,000 recorded in FY2023.
  • Over the past 5 years, Niagen Bioscience's Change in Account Payables peaked at $978,000 during FY2021, and registered a low of -$1.1 million during FY2024.
  • In the last 3 years, Niagen Bioscience's Change in Account Payables had a median value of -$744,000 in 2022 and averaged -$419,333.
  • In the last 5 years, Niagen Bioscience's Change in Account Payables slumped by 332.05% in 2020 and then skyrocketed by 640.33% in 2021.
  • Niagen Bioscience's Change in Account Payables (Yearly) stood at -$181,000 in 2020, then surged by 640.33% to $978,000 in 2021, then crashed by 176.07% to -$744,000 in 2022, then spiked by 174.33% to $553,000 in 2023, then plummeted by 292.95% to -$1.1 million in 2024.